dapi has been researched along with Ophthalmoplegia, Progressive Supranuclear in 1 studies
DAPI: RN given refers to parent cpd.
| Excerpt | Relevance | Reference |
|---|---|---|
| "DAPI was positive in 3R/4R (3-repeat/4-repeat) tau deposits in Alzheimer's disease, myotonic dystrophy, and neurodegeneration with brain iron accumulation, and in 4R tau deposits in corticobasal degeneration, but negative in 4R tau deposits in frontotemporal dementia with parkinsonism-17 and progressive supranuclear palsy." | 1.48 | 4',6-Diamidino-2-Phenylindole Distinctly Labels Tau Deposits. ( Kinoshita, E; Li, C; Maruyama, H; Matsubara, T; Matsumoto, M; Shrestha, T; Takahashi, T, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, C | 1 |
| Takahashi, T | 1 |
| Shrestha, T | 1 |
| Kinoshita, E | 1 |
| Matsubara, T | 1 |
| Matsumoto, M | 1 |
| Maruyama, H | 1 |
1 other study available for dapi and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
4',6-Diamidino-2-Phenylindole Distinctly Labels Tau Deposits.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Fluorescent Dyes; Frontotemporal Dementia; Humans | 2018 |